Shire Viropharma Inc (VPHM)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre

Cours de l'action
Code mnémonique : VPHM Marché : NSQ


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette Résultats financiers
Résultats financiers
 
Value bought

90 derniers jours

 
Value sold

90 derniers jours

 
Net insiders buying

90 derniers jours

 
Trades (buy and sell)

90 derniers jours

Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur Détails
2012-12-27 2012-12-24 VP Vente planifiée

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
17 500 -31.7%
22,53
394 301 USD 		17 500 -31.7% 22,53 394 301 USD
2012-12-17 2012-12-13 V Vente

BROOKE PAUL A

Administrateur non-exécutif
60 000 -36.5%
23,87
1 431 954 USD 		60 000 -36.5% 23,87 1 431 954 USD
2012-12-12 2012-12-10 VP Vente planifiée

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
14 999 -28.5%
24,07
360 984 USD 		14 999 -28.5% 24,07 360 984 USD
2012-12-12 2012-12-10 V Vente

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
50 000 -57.0%
24,07
1 203 360 USD 		50 000 -57.0% 24,07 1 203 360 USD
2012-12-12 2012-12-10 V Vente

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
10 000 -21.0%
24,07
240 672 USD 		10 000 -21.0% 24,07 240 672 USD
2012-12-05 2012-12-03 V Vente

Wolf John Peter III

VP, General Counsel

Dirigeant
18 000 -100.0%
24,85
447 257 USD 		18 000 -100.0% 24,85 447 257 USD
2012-12-05 2012-12-03 A Achat

DOUGHERTY MICHAEL R

Administrateur non-exécutif
2 500 +55.6%
25,07
62 675 USD 		2 500 +55.6% 25,07 62 675 USD
2012-12-05 2012-12-03 V Vente

CLAYPOOL WILLIAM D MD

Administrateur non-exécutif
10 000 -18.3%
24,80
248 000 USD 		10 000 -18.3% 24,80 248 000 USD
2012-12-04 2012-11-30 V Vente

GLASER ROBERT

Administrateur non-exécutif
10 000 -19.5%
24,78
247 795 USD 		10 000 -19.5% 24,78 247 795 USD
2012-12-04 2012-11-30 V Vente

GLASER ROBERT

Administrateur non-exécutif
20 000 -32.6%
24,78
495 590 USD 		20 000 -32.6% 24,78 495 590 USD
2012-11-30 2012-11-28 V Vente

CLAYPOOL WILLIAM D MD

Administrateur non-exécutif
15 000 -21.6%
24,22
363 326 USD 		15 000 -21.6% 24,22 363 326 USD
2012-11-30 2012-11-28 V Vente

CLAYPOOL WILLIAM D MD

Administrateur non-exécutif
2 500 -4.4%
24,22
60 554 USD 		2 500 -4.4% 24,22 60 554 USD
2012-11-15 2012-11-13 V Vente

CLAYPOOL WILLIAM D MD

Administrateur non-exécutif
12 500 -18.7%
25,01
312 585 USD 		12 500 -18.7% 25,01 312 585 USD
2012-11-15 2012-11-13 V Vente

CLAYPOOL WILLIAM D MD

Administrateur non-exécutif
10 000 -15.5%
24,84
248 426 USD 		10 000 -15.5% 24,84 248 426 USD
2012-11-13 2012-11-08 V Vente

MILANO VINCENT

President and CEO

Administrateur exécutif
41 418 -30.5%
24,54
1 016 522 USD 		41 418 -30.5% 24,54 1 016 522 USD
2012-11-13 2012-11-08 V Vente

MILANO VINCENT

President and CEO

Administrateur exécutif
42 000 -30.8%
24,54
1 030 806 USD 		42 000 -30.8% 24,54 1 030 806 USD
2012-11-05 2012-11-02 V Vente

CLAYPOOL WILLIAM D MD

Administrateur non-exécutif
10 000 -15.5%
25,37
253 703 USD 		10 000 -15.5% 25,37 253 703 USD
2012-06-13 2012-06-11 V Vente

CLAYPOOL WILLIAM D MD

Administrateur non-exécutif
10 000 -13.4%
20,04
200 430 USD 		10 000 -13.4% 20,04 200 430 USD
2012-03-27 2012-03-23 VP Vente planifiée

Pietrusko Robert

VP, Regulatory & Quality

Dirigeant
20 000 -82.9%
30,00
600 000 USD 		20 000 -82.9% 30,00 600 000 USD
2012-03-12 2012-03-09 V Vente

Morris Richard Steven

Chief Accounting Officer

Dirigeant
1 300 -51.1%
29,71
38 618 USD 		1 300 -51.1% 29,71 38 618 USD
2012-03-12 2012-03-09 V Vente

Fletcher Robert C.

V.P., Business Development

Dirigeant
32 000 -99.3%
29,65
948 954 USD 		32 000 -99.3% 29,65 948 954 USD
2012-03-07 2012-03-05 V Vente

Morris Richard Steven

Chief Accounting Officer

Dirigeant
5 300 -81.0%
33,01
174 953 USD 		5 300 -81.0% 33,01 174 953 USD
2012-03-07 2012-03-05 V Vente

DOYLE THOMAS F

VP Strategic Initiatives

Dirigeant
210 000 -80.0%
32,48
6 820 212 USD 		210 000 -80.0% 32,48 6 820 212 USD
2012-03-06 2012-03-01 V Vente

SOLAND DANIEL B

VP, Chief Operating Officer

Dirigeant
30 000 -41.2%
32,99
989 700 USD 		30 000 -41.2% 32,99 989 700 USD
2012-03-05 2012-03-01 V Vente

Rowland Charles A Jr

VP, Chief Financial Officer

Dirigeant
12 750 -42.7%
32,11
409 434 USD 		12 750 -42.7% 32,11 409 434 USD
2012-03-05 2012-03-01 V Vente

Rowland Charles A Jr

VP, Chief Financial Officer

Dirigeant
70 000 -70.1%
32,12
2 248 197 USD 		70 000 -70.1% 32,12 2 248 197 USD
2011-12-16 2011-12-14 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
50 566 +2.6%
27,29
1 379 860 USD 		50 566 +2.6% 27,29 1 379 860 USD
2011-12-16 2011-12-14 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
291 706 +3.1%
27,29
7 960 161 USD 		291 706 +3.1% 27,29 7 960 161 USD
2011-12-16 2011-12-14 A Achat

14159 capital (GP), LLC

Actionnaire important
7 828 +2.6%
27,29
213 613 USD 		7 828 +2.6% 27,29 213 613 USD
2011-12-15 2011-12-14 VP Vente planifiée

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
25 000 -56.3%
25,17
629 250 USD 		25 000 -56.3% 25,17 629 250 USD
2011-12-15 2011-12-14 VP Vente planifiée

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
25 000 -56.3%
25,50
637 500 USD 		25 000 -56.3% 25,50 637 500 USD
2011-12-14 2011-12-13 VP Vente planifiée

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
22 330 -53.5%
23,50
524 755 USD 		22 330 -53.5% 23,50 524 755 USD
2011-12-14 2011-12-12 VP Vente planifiée

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
17 670 -47.6%
23,50
415 317 USD 		17 670 -47.6% 23,50 415 317 USD
2011-12-05 2011-12-01 V Vente

DOYLE THOMAS F

VP Strategic Initiatives

Dirigeant
10 000 -16.0%
23,82
238 159 USD 		10 000 -16.0% 23,82 238 159 USD
2011-12-01 2011-11-30 VP Vente planifiée

Pietrusko Robert

VP, Regulatory & Quality

Dirigeant
20 000 -83.6%
24,00
480 000 USD 		20 000 -83.6% 24,00 480 000 USD
2011-11-29 2011-11-28 VP Vente planifiée

Pietrusko Robert

VP, Regulatory & Quality

Dirigeant
19 000 -82.9%
23,00
437 000 USD 		19 000 -82.9% 23,00 437 000 USD
2011-11-29 2011-11-28 V Vente

GLASER ROBERT

Administrateur non-exécutif
5 000 -11.9%
23,00
115 000 USD 		5 000 -11.9% 23,00 115 000 USD
2011-11-28 2011-11-23 VP Vente planifiée

Pietrusko Robert

VP, Regulatory & Quality

Dirigeant
1 000 -25.6%
23,00
23 000 USD 		1 000 -25.6% 23,00 23 000 USD
2011-11-23 2011-11-21 VP Vente planifiée

MILANO VINCENT

President and CEO

Administrateur exécutif
41 691 -35.4%
22,53
939 127 USD 		41 691 -35.4% 22,53 939 127 USD
2011-11-23 2011-11-21 VP Vente planifiée

MILANO VINCENT

President and CEO

Administrateur exécutif
19 996 -20.8%
22,53
450 428 USD 		19 996 -20.8% 22,53 450 428 USD
2011-11-23 2011-11-21 VP Vente planifiée

MILANO VINCENT

President and CEO

Administrateur exécutif
15 000 -16.4%
22,53
337 889 USD 		15 000 -16.4% 22,53 337 889 USD
2011-11-17 2011-11-16 V Vente

Morris Richard Steven

Chief Accounting Officer

Dirigeant
2 000 -63.2%
22,59
45 181 USD 		2 000 -63.2% 22,59 45 181 USD
2011-11-15 2011-11-14 VP Vente planifiée

Pietrusko Robert

VP, Regulatory & Quality

Dirigeant
20 000 -83.6%
22,00
440 000 USD 		20 000 -83.6% 22,00 440 000 USD
2011-11-09 2011-11-07 V Vente

Wolf John Peter III

VP, General Counsel

Dirigeant
12 250 -100.0%
21,08
258 194 USD 		12 250 -100.0% 21,08 258 194 USD
2011-11-08 2011-11-07 V Vente

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
200 -1.0%
21,01
4 202 USD 		200 -1.0% 21,01 4 202 USD
2011-11-08 2011-11-07 V Vente

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
19 800 -50.2%
21,00
415 800 USD 		19 800 -50.2% 21,00 415 800 USD
2011-11-02 2011-11-01 VP Vente planifiée

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
24 121 -55.4%
20,05
483 641 USD 		24 121 -55.4% 20,05 483 641 USD
2011-11-02 2011-10-31 V Vente

Broom Colin MD

VP & Chief Scientific Officer

Dirigeant
20 495 -51.3%
20,42
418 555 USD 		20 495 -51.3% 20,42 418 555 USD
2011-10-06 2011-10-05 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
145 763 +1.6%
18,18
2 650 423 USD 		145 763 +1.6% 18,18 2 650 423 USD
2011-10-06 2011-10-05 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
16 278 +0.9%
18,18
295 985 USD 		16 278 +0.9% 18,18 295 985 USD
2011-10-06 2011-10-05 A Achat

14159 capital (GP), LLC

Actionnaire important
6 017 +2.1%
18,18
109 408 USD 		6 017 +2.1% 18,18 109 408 USD
2011-10-06 2011-10-04 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
45 584 +0.5%
17,48
796 644 USD 		45 584 +0.5% 17,48 796 644 USD
2011-10-06 2011-10-04 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
2 511 +0.1%
17,48
43 883 USD 		2 511 +0.1% 17,48 43 883 USD
2011-10-06 2011-10-04 A Achat

14159 capital (GP), LLC

Actionnaire important
1 905 +0.7%
17,48
33 293 USD 		1 905 +0.7% 17,48 33 293 USD
2011-10-03 2011-10-03 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
445 574 +5.0%
17,71
7 890 269 USD 		445 574 +5.0% 17,71 7 890 269 USD
2011-10-03 2011-10-03 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
70 629 +0.8%
17,62
1 244 589 USD 		70 629 +0.8% 17,62 1 244 589 USD
2011-10-03 2011-09-30 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
88 657 +1.0%
18,08
1 602 892 USD 		88 657 +1.0% 18,08 1 602 892 USD
2011-10-03 2011-09-30 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
43 321 +0.5%
18,19
788 122 USD 		43 321 +0.5% 18,19 788 122 USD
2011-10-03 2011-09-30 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
13 576 +0.7%
18,08
245 450 USD 		13 576 +0.7% 18,08 245 450 USD
2011-10-03 2011-09-30 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
6 634 +0.4%
18,19
120 690 USD 		6 634 +0.4% 18,19 120 690 USD
2011-10-03 2011-09-30 A Achat

14159 capital (GP), LLC

Actionnaire important
3 367 +1.2%
18,08
60 874 USD 		3 367 +1.2% 18,08 60 874 USD
2011-10-03 2011-09-30 A Achat

14159 capital (GP), LLC

Actionnaire important
1 645 +0.6%
18,19
29 927 USD 		1 645 +0.6% 18,19 29 927 USD
2011-10-03 2011-09-29 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
159 945 +1.9%
18,00
2 878 882 USD 		159 945 +1.9% 18,00 2 878 882 USD
2011-10-03 2011-09-29 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
21 117 +1.1%
18,00
380 089 USD 		21 117 +1.1% 18,00 380 089 USD
2011-10-03 2011-09-29 A Achat

14159 capital (GP), LLC

Actionnaire important
6 084 +2.2%
18,00
109 507 USD 		6 084 +2.2% 18,00 109 507 USD
2011-10-03 2011-09-29 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
89 970 +1.1%
17,97
1 616 392 USD 		89 970 +1.1% 17,97 1 616 392 USD
2011-10-03 2011-09-29 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
11 878 +0.6%
17,97
213 399 USD 		11 878 +0.6% 17,97 213 399 USD
2011-10-03 2011-09-29 A Achat

14159 capital (GP), LLC

Actionnaire important
3 423 +1.3%
17,97
61 497 USD 		3 423 +1.3% 17,97 61 497 USD
2011-09-26 2011-09-26 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
4 697 +0.3%
18,13
85 155 USD 		4 697 +0.3% 18,13 85 155 USD
2011-09-26 2011-09-26 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
22 084 +1.2%
18,13
400 295 USD 		22 084 +1.2% 18,13 400 295 USD
2011-09-26 2011-09-26 A Achat

14159 capital (GP), LLC

Actionnaire important
1 103 +0.4%
18,13
19 997 USD 		1 103 +0.4% 18,13 19 997 USD
2011-09-26 2011-09-26 A Achat

14159 capital (GP), LLC

Actionnaire important
5 184 +1.9%
18,13
93 965 USD 		5 184 +1.9% 18,13 93 965 USD
2011-09-26 2011-09-26 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
28 000 +0.3%
18,13
507 632 USD 		28 000 +0.3% 18,13 507 632 USD
2011-09-26 2011-09-26 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
131 641 +1.6%
18,13
2 386 125 USD 		131 641 +1.6% 18,13 2 386 125 USD
2011-09-26 2011-09-23 A Achat

Baker Biotech Capital (GP), LLC

Actionnaire important
8 828 +0.5%
17,78
156 988 USD 		8 828 +0.5% 17,78 156 988 USD
// ... existing code ... // ... rest of the file ...